B
Encompass Health Corporation
EHC
$99.25
-$0.42-0.42%
B
Buy
3/3/2025Upgraded
Encompass Health Corporation (EHC) was upgraded to B from B- on 3/3/2025 due to a large increase in the growth index, volatility index and valuation index. Earnings per share increased from $1.0597 to $1.1818, EBIT increased 11.1% from $209.1M to $232.3M, and operating cash flow increased 4.11% from $267.8M to $278.8M.
Encompass Health Corporation (EHC) was upgraded to B from B- on 3/3/2025 due to a large increase in the growth index, volatility index and valuation index. Earnings per share increased from $1.0597 to $1.1818, EBIT increased 11.1% from $209.1M to $232.3M, and operating cash flow increased 4.11% from $267.8M to $278.8M.
B
Buy
10/17/2024Upgraded
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 10/17/2024 due to an increase in the volatility index and total return index.
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 10/17/2024 due to an increase in the volatility index and total return index.
C
Hold
8/8/2024Downgrade
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 8/8/2024 due to a noticeable decline in the growth index, valuation index and efficiency index. Operating cash flow declined 8.96% from $238.8M to $217.4M, and total revenue declined 1.12% from $1.32B to $1.3B.
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 8/8/2024 due to a noticeable decline in the growth index, valuation index and efficiency index. Operating cash flow declined 8.96% from $238.8M to $217.4M, and total revenue declined 1.12% from $1.32B to $1.3B.
B
Buy
6/25/2024Upgraded
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 6/25/2024 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from $0.8631 to $1.1008, operating cash flow increased 18.81% from $201M to $238.8M, and EBIT increased 9.27% from $189.9M to $207.5M.
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 6/25/2024 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from $0.8631 to $1.1008, operating cash flow increased 18.81% from $201M to $238.8M, and EBIT increased 9.27% from $189.9M to $207.5M.
C
Hold
2/15/2024Upgraded
Encompass Health Corporation (EHC) was upgraded to C+ from C on 2/15/2024 due to a major increase in the growth index, total return index and solvency index. Debt to equity declined from 1.64 to 1.55, operating cash flow increased 4.11% from $206.7M to $215.2M, and total revenue increased 1.67% from $1.19B to $1.21B.
Encompass Health Corporation (EHC) was upgraded to C+ from C on 2/15/2024 due to a major increase in the growth index, total return index and solvency index. Debt to equity declined from 1.64 to 1.55, operating cash flow increased 4.11% from $206.7M to $215.2M, and total revenue increased 1.67% from $1.19B to $1.21B.
C
Hold
3/9/2023Upgraded
Encompass Health Corporation (EHC) was upgraded to C from C- on 3/9/2023 due to an increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.4517 to $0.8869, EBIT increased 21.09% from $148.4M to $179.7M, and the quick ratio increased from 0.93 to 0.97.
Encompass Health Corporation (EHC) was upgraded to C from C- on 3/9/2023 due to an increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.4517 to $0.8869, EBIT increased 21.09% from $148.4M to $179.7M, and the quick ratio increased from 0.93 to 0.97.
C
Hold
12/14/2022Upgraded
Encompass Health Corporation (EHC) was upgraded to C- from D+ on 12/14/2022 due to an increase in the total return index and volatility index.
Encompass Health Corporation (EHC) was upgraded to C- from D+ on 12/14/2022 due to an increase in the total return index and volatility index.
D
Sell
11/22/2022Downgrade
Encompass Health Corporation (EHC) was downgraded to D+ from C- on 11/22/2022 due to a significant decline in the growth index, valuation index and solvency index. Debt to equity increased from 1.49 to 1.85, the quick ratio declined from 1.01 to 0.93, and earnings per share declined from $0.486 to $0.4517.
Encompass Health Corporation (EHC) was downgraded to D+ from C- on 11/22/2022 due to a significant decline in the growth index, valuation index and solvency index. Debt to equity increased from 1.49 to 1.85, the quick ratio declined from 1.01 to 0.93, and earnings per share declined from $0.486 to $0.4517.
C
Hold
7/18/2022Downgrade
Encompass Health Corporation (EHC) was downgraded to C- from C on 7/18/2022 due to a decline in the volatility index, solvency index and efficiency index. Net income declined 4.48% from $91.6M to $87.5M.
Encompass Health Corporation (EHC) was downgraded to C- from C on 7/18/2022 due to a decline in the volatility index, solvency index and efficiency index. Net income declined 4.48% from $91.6M to $87.5M.
C
Hold
1/10/2022Upgraded
Encompass Health Corporation (EHC) was upgraded to C from C- on 1/10/2022 due to an increase in the volatility index.
Encompass Health Corporation (EHC) was upgraded to C from C- on 1/10/2022 due to an increase in the volatility index.
C
Hold
12/22/2021Downgrade
Encompass Health Corporation (EHC) was downgraded to C- from C on 12/22/2021 due to a large decline in the total return index, growth index and solvency index. Earnings per share declined from $1.1277 to $0.998, EBIT declined 8.9% from $219M to $199.5M, and total revenue declined 0.23% from $1.29B to $1.28B.
Encompass Health Corporation (EHC) was downgraded to C- from C on 12/22/2021 due to a large decline in the total return index, growth index and solvency index. Earnings per share declined from $1.1277 to $0.998, EBIT declined 8.9% from $219M to $199.5M, and total revenue declined 0.23% from $1.29B to $1.28B.
C
Hold
11/3/2021Downgrade
Encompass Health Corporation (EHC) was downgraded to C from C+ on 11/3/2021 due to a noticeable decline in the volatility index, total return index and growth index.
Encompass Health Corporation (EHC) was downgraded to C from C+ on 11/3/2021 due to a noticeable decline in the volatility index, total return index and growth index.
C
Hold
9/13/2021Downgrade
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 9/13/2021 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.06 to 0.87.
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 9/13/2021 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.06 to 0.87.
B
Buy
4/7/2021Upgraded
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 4/7/2021 due to an increase in the total return index and volatility index.
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 4/7/2021 due to an increase in the total return index and volatility index.
C
Hold
3/23/2021Downgrade
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 3/23/2021 due to a decline in the total return index and volatility index.
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 3/23/2021 due to a decline in the total return index and volatility index.
B
Buy
3/8/2021Upgraded
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 3/8/2021 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 61.3% from $173.4M to $279.7M, EBIT increased 11.88% from $172.5M to $193M, and earnings per share increased from $0.78 to $0.8591.
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 3/8/2021 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 61.3% from $173.4M to $279.7M, EBIT increased 11.88% from $172.5M to $193M, and earnings per share increased from $0.78 to $0.8591.
C
Hold
11/20/2020Upgraded
Encompass Health Corporation (EHC) was upgraded to C+ from C on 11/20/2020 due to a major increase in the growth index and solvency index. Earnings per share increased from $0.3394 to $0.78, EBIT increased 73.72% from $99.3M to $172.5M, and total revenue increased 9.29% from $1.07B to $1.17B.
Encompass Health Corporation (EHC) was upgraded to C+ from C on 11/20/2020 due to a major increase in the growth index and solvency index. Earnings per share increased from $0.3394 to $0.78, EBIT increased 73.72% from $99.3M to $172.5M, and total revenue increased 9.29% from $1.07B to $1.17B.
C
Hold
8/4/2020Downgrade
Encompass Health Corporation (EHC) was downgraded to C from C+ on 8/4/2020 due to a decline in the valuation index, total return index and efficiency index. Net income declined 61.49% from $87M to $33.5M.
Encompass Health Corporation (EHC) was downgraded to C from C+ on 8/4/2020 due to a decline in the valuation index, total return index and efficiency index. Net income declined 61.49% from $87M to $33.5M.
C
Hold
6/22/2020Upgraded
Encompass Health Corporation (EHC) was upgraded to C+ from C on 6/22/2020 due to an increase in the valuation index and dividend index.
Encompass Health Corporation (EHC) was upgraded to C+ from C on 6/22/2020 due to an increase in the valuation index and dividend index.
C
Hold
6/2/2020Downgrade
Encompass Health Corporation (EHC) was downgraded to C from C+ on 6/2/2020 due to a significant decline in the growth index, valuation index and volatility index. Operating cash flow declined 86.41% from $215.6M to $29.3M, and total revenue declined 0.2% from $1.18B to $1.18B.
Encompass Health Corporation (EHC) was downgraded to C from C+ on 6/2/2020 due to a significant decline in the growth index, valuation index and volatility index. Operating cash flow declined 86.41% from $215.6M to $29.3M, and total revenue declined 0.2% from $1.18B to $1.18B.
C
Hold
5/8/2020Downgrade
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 5/8/2020 due to a decline in the valuation index, volatility index and total return index.
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 5/8/2020 due to a decline in the valuation index, volatility index and total return index.
B
Buy
3/20/2020Downgrade
Encompass Health Corporation (EHC) was downgraded to B- from B on 3/20/2020 due to a decline in the total return index and volatility index.
Encompass Health Corporation (EHC) was downgraded to B- from B on 3/20/2020 due to a decline in the total return index and volatility index.
B
Buy
3/5/2020Upgraded
Encompass Health Corporation (EHC) was upgraded to B from B- on 3/5/2020 due to a large increase in the growth index, total return index and valuation index. Operating cash flow increased 88.46% from $114.4M to $215.6M, and total revenue increased 1.96% from $1.16B to $1.18B.
Encompass Health Corporation (EHC) was upgraded to B from B- on 3/5/2020 due to a large increase in the growth index, total return index and valuation index. Operating cash flow increased 88.46% from $114.4M to $215.6M, and total revenue increased 1.96% from $1.16B to $1.18B.
B
Buy
1/15/2020Upgraded
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 1/15/2020 due to an increase in the volatility index, total return index and solvency index.
Encompass Health Corporation (EHC) was upgraded to B- from C+ on 1/15/2020 due to an increase in the volatility index, total return index and solvency index.
C
Hold
8/2/2019Downgrade
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 8/2/2019 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from $1.0261 to $0.9184, operating cash flow declined 9.07% from $159.9M to $145.4M, and EBIT declined 9.07% from $187.5M to $170.5M.
Encompass Health Corporation (EHC) was downgraded to C+ from B- on 8/2/2019 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from $1.0261 to $0.9184, operating cash flow declined 9.07% from $159.9M to $145.4M, and EBIT declined 9.07% from $187.5M to $170.5M.
B
Buy
3/29/2019Downgrade
Encompass Health Corporation (EHC) was downgraded to B- from B on 3/29/2019 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from $0.886 to $0.281, operating cash flow declined 10.13% from $198.5M to $178.4M, and EBIT declined 6.01% from $173.1M to $162.7M.
Encompass Health Corporation (EHC) was downgraded to B- from B on 3/29/2019 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from $0.886 to $0.281, operating cash flow declined 10.13% from $198.5M to $178.4M, and EBIT declined 6.01% from $173.1M to $162.7M.
B
Buy
12/13/2018Downgrade
Encompass Health Corporation (EHC) was downgraded to B from B+ on 12/13/2018 due to a decline in the total return index and volatility index.
Encompass Health Corporation (EHC) was downgraded to B from B+ on 12/13/2018 due to a decline in the total return index and volatility index.
B
Buy
12/11/2018Downgrade
Encompass Health Corporation (EHC) was downgraded to B+ from A- on 12/11/2018 due to a noticeable decline in the total return index, valuation index and volatility index.
Encompass Health Corporation (EHC) was downgraded to B+ from A- on 12/11/2018 due to a noticeable decline in the total return index, valuation index and volatility index.
A
Buy
11/26/2018Upgraded
Encompass Health Corporation (EHC) was upgraded to A- from B+ on 11/26/2018 due to an increase in the volatility index.
Encompass Health Corporation (EHC) was upgraded to A- from B+ on 11/26/2018 due to an increase in the volatility index.
B
Buy
11/7/2018Downgrade
Encompass Health Corporation (EHC) was downgraded to B+ from A- on 11/7/2018 due to a decline in the growth index, volatility index and total return index. Earnings per share declined from $0.9217 to $0.886, EBIT declined 2.04% from $176.7M to $173.1M, and total revenue declined 0.01% from $1.07B to $1.07B.
Encompass Health Corporation (EHC) was downgraded to B+ from A- on 11/7/2018 due to a decline in the growth index, volatility index and total return index. Earnings per share declined from $0.9217 to $0.886, EBIT declined 2.04% from $176.7M to $173.1M, and total revenue declined 0.01% from $1.07B to $1.07B.
A
Buy
10/29/2018Downgrade
Encompass Health Corporation (EHC) was downgraded to A- from A on 10/29/2018 due to a large decline in the total return index.
Encompass Health Corporation (EHC) was downgraded to A- from A on 10/29/2018 due to a large decline in the total return index.
A
Buy
10/8/2018Upgraded
Encompass Health Corporation (EHC) was upgraded to A from A- on 10/8/2018 due to an increase in the volatility index, total return index and valuation index.
Encompass Health Corporation (EHC) was upgraded to A from A- on 10/8/2018 due to an increase in the volatility index, total return index and valuation index.
A
Buy
10/1/2018Upgraded
Encompass Health Corporation (EHC) was upgraded to A- from B+ on 10/1/2018 due to an increase in the volatility index, total return index and efficiency index. Net income increased 9.55% from $83.8M to $91.8M, and total capital increased 3.44% from $4.22B to $4.36B.
Encompass Health Corporation (EHC) was upgraded to A- from B+ on 10/1/2018 due to an increase in the volatility index, total return index and efficiency index. Net income increased 9.55% from $83.8M to $91.8M, and total capital increased 3.44% from $4.22B to $4.36B.
B
Buy
7/18/2018Upgraded
Encompass Health Corporation (EHC) was upgraded to B+ from B on 7/18/2018 due to a major increase in the total return index, volatility index and solvency index.
Encompass Health Corporation (EHC) was upgraded to B+ from B on 7/18/2018 due to a major increase in the total return index, volatility index and solvency index.
B
Buy
4/28/2017Upgraded
HealthSouth Corporation (HLS) was upgraded to B from B- on 4/28/2017 due to a noticeable increase in the growth index, volatility index and efficiency index. Operating cash flow increased 55.86% from $116M to $180.8M, EBIT increased 3.9% from $156.5M to $162.6M, and total revenue increased 2.46% from $935.4M to $958.4M.
HealthSouth Corporation (HLS) was upgraded to B from B- on 4/28/2017 due to a noticeable increase in the growth index, volatility index and efficiency index. Operating cash flow increased 55.86% from $116M to $180.8M, EBIT increased 3.9% from $156.5M to $162.6M, and total revenue increased 2.46% from $935.4M to $958.4M.
B
Buy
2/24/2017Upgraded
HealthSouth Corporation (HLS) was upgraded to B- from C+ on 2/24/2017 due to a noticeable increase in the growth index, total return index and valuation index. Earnings per share increased from $0.6449 to $0.6835, and total revenue increased 2.57% from $912M to $935.4M.
HealthSouth Corporation (HLS) was upgraded to B- from C+ on 2/24/2017 due to a noticeable increase in the growth index, total return index and valuation index. Earnings per share increased from $0.6449 to $0.6835, and total revenue increased 2.57% from $912M to $935.4M.
C
Hold
2/13/2017Downgrade
HealthSouth Corporation (HLS) was downgraded to C+ from B- on 2/13/2017 due to a decline in the total return index and volatility index.
HealthSouth Corporation (HLS) was downgraded to C+ from B- on 2/13/2017 due to a decline in the total return index and volatility index.
B
Buy
1/9/2017Downgrade
HealthSouth Corporation (HLS) was downgraded to B- from B on 1/9/2017 due to a decline in the volatility index.
HealthSouth Corporation (HLS) was downgraded to B- from B on 1/9/2017 due to a decline in the volatility index.
B
Buy
12/23/2016Upgraded
HealthSouth Corporation (HLS) was upgraded to B from B- on 12/23/2016 due to a noticeable increase in the volatility index, total return index and valuation index.
HealthSouth Corporation (HLS) was upgraded to B from B- on 12/23/2016 due to a noticeable increase in the volatility index, total return index and valuation index.
B
Buy
5/20/2016Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to B- from C+ on 5/20/2016 due to a large increase in the growth index, volatility index and solvency index. Operating cash flow increased 36.96% from $116.6M to $159.7M, earnings per share increased from $0.4911 to $0.6076, and debt to equity declined from 5.19 to 4.8.
HEALTHSOUTH Corp. (HLS) was upgraded to B- from C+ on 5/20/2016 due to a large increase in the growth index, volatility index and solvency index. Operating cash flow increased 36.96% from $116.6M to $159.7M, earnings per share increased from $0.4911 to $0.6076, and debt to equity declined from 5.19 to 4.8.
C
Hold
4/20/2016Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to C+ from C on 4/20/2016 due to an increase in the volatility index.
HEALTHSOUTH Corp. (HLS) was upgraded to C+ from C on 4/20/2016 due to an increase in the volatility index.
C
Hold
3/11/2016Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to C from B- on 3/11/2016 due to a large decline in the volatility index, growth index and valuation index. Operating cash flow declined 28.6% from $163.3M to $116.6M, and earnings per share declined from $0.5232 to $0.4911.
HEALTHSOUTH Corp. (HLS) was downgraded to C from B- on 3/11/2016 due to a large decline in the volatility index, growth index and valuation index. Operating cash flow declined 28.6% from $163.3M to $116.6M, and earnings per share declined from $0.5232 to $0.4911.
B
Buy
1/15/2016Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to B- from B on 1/15/2016 due to a noticeable decline in the total return index.
HEALTHSOUTH Corp. (HLS) was downgraded to B- from B on 1/15/2016 due to a noticeable decline in the total return index.
B
Buy
12/31/2015Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to B from B- on 12/31/2015 due to a noticeable increase in the total return index and valuation index.
HEALTHSOUTH Corp. (HLS) was upgraded to B from B- on 12/31/2015 due to a noticeable increase in the total return index and valuation index.
B
Buy
12/11/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to B- from B on 12/11/2015 due to a noticeable decline in the volatility index and total return index.
HEALTHSOUTH Corp. (HLS) was downgraded to B- from B on 12/11/2015 due to a noticeable decline in the volatility index and total return index.
B
Buy
11/12/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to B from B+ on 11/12/2015 due to a significant decline in the volatility index, total return index and efficiency index.
HEALTHSOUTH Corp. (HLS) was downgraded to B from B+ on 11/12/2015 due to a significant decline in the volatility index, total return index and efficiency index.
B
Buy
9/14/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to B+ from A- on 9/14/2015 due to a decline in the volatility index and total return index.
HEALTHSOUTH Corp. (HLS) was downgraded to B+ from A- on 9/14/2015 due to a decline in the volatility index and total return index.
A
Buy
8/17/2015Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to A- from B+ on 8/17/2015 due to an increase in the total return index, volatility index and valuation index.
HEALTHSOUTH Corp. (HLS) was upgraded to A- from B+ on 8/17/2015 due to an increase in the total return index, volatility index and valuation index.
B
Buy
7/31/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to B+ from A- on 7/31/2015 due to a noticeable decline in the growth index, total return index and valuation index.
HEALTHSOUTH Corp. (HLS) was downgraded to B+ from A- on 7/31/2015 due to a noticeable decline in the growth index, total return index and valuation index.
A
Buy
7/15/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to A- from A on 7/15/2015 due to a noticeable decline in the total return index and volatility index.
HEALTHSOUTH Corp. (HLS) was downgraded to A- from A on 7/15/2015 due to a noticeable decline in the total return index and volatility index.
A
Buy
6/25/2015Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to A from A- on 6/25/2015 due to a noticeable increase in the total return index and volatility index.
HEALTHSOUTH Corp. (HLS) was upgraded to A from A- on 6/25/2015 due to a noticeable increase in the total return index and volatility index.
A
Buy
6/10/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to A- from A on 6/10/2015 due to a decline in the total return index and valuation index.
HEALTHSOUTH Corp. (HLS) was downgraded to A- from A on 6/10/2015 due to a decline in the total return index and valuation index.
A
Buy
5/18/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to A from A+ on 5/18/2015 due to a noticeable decline in the total return index and volatility index.
HEALTHSOUTH Corp. (HLS) was downgraded to A from A+ on 5/18/2015 due to a noticeable decline in the total return index and volatility index.
A
Buy
5/1/2015Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to A+ from A- on 5/1/2015 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 45.3% from $70.2M to $102M, total revenue increased 20.14% from $606.8M to $729M, and EBIT increased 8.53% from $118.4M to $128.5M.
HEALTHSOUTH Corp. (HLS) was upgraded to A+ from A- on 5/1/2015 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 45.3% from $70.2M to $102M, total revenue increased 20.14% from $606.8M to $729M, and EBIT increased 8.53% from $118.4M to $128.5M.
A
Buy
3/4/2015Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to A- from B- on 3/4/2015 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 4.32% from $113.5M to $118.4M, and total revenue increased 3.07% from $588.7M to $606.8M.
HEALTHSOUTH Corp. (HLS) was upgraded to A- from B- on 3/4/2015 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 4.32% from $113.5M to $118.4M, and total revenue increased 3.07% from $588.7M to $606.8M.
B
Buy
1/26/2015Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to B- from B on 1/26/2015 due to a noticeable decline in the growth index, total return index and valuation index. Earnings per share declined from $0.8489 to $0.5214, EBIT declined 10.49% from $126.8M to $113.5M, and total revenue declined 1.08% from $595.1M to $588.7M.
HEALTHSOUTH Corp. (HLS) was downgraded to B- from B on 1/26/2015 due to a noticeable decline in the growth index, total return index and valuation index. Earnings per share declined from $0.8489 to $0.5214, EBIT declined 10.49% from $126.8M to $113.5M, and total revenue declined 1.08% from $595.1M to $588.7M.
B
Buy
7/31/2014Downgrade
HEALTHSOUTH Corp. (HLS) was downgraded to B from A- on 7/31/2014 due to a significant decline in the growth index, valuation index and efficiency index.
HEALTHSOUTH Corp. (HLS) was downgraded to B from A- on 7/31/2014 due to a significant decline in the growth index, valuation index and efficiency index.
A
Buy
6/12/2014Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to A- from B+ on 6/12/2014 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 6.14% from $100.9M to $107.1M, and total revenue increased 2.67% from $568.5M to $583.7M.
HEALTHSOUTH Corp. (HLS) was upgraded to A- from B+ on 6/12/2014 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 6.14% from $100.9M to $107.1M, and total revenue increased 2.67% from $568.5M to $583.7M.
B
Buy
3/25/2014Upgraded
HEALTHSOUTH Corp. (HLS) was upgraded to B+ from B on 3/25/2014 due to an increase in the volatility index, growth index and solvency index.
HEALTHSOUTH Corp. (HLS) was upgraded to B+ from B on 3/25/2014 due to an increase in the volatility index, growth index and solvency index.
NYSE
03/07/2025 4:00PM Eastern
Quotes delayed
